Carla Mottini

Closest collaborators

The 16 strongest of 16 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Luca Cardone · 2 shared papers, 2019–2025 · strength 0.31
   • Paper Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors. DOI 10.1016/j.isci.2025.111842↗
   • Paper Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocar… DOI 10.1158/0008-5472.can-19-0187↗
2. Giorgia Anastasio · 1 shared paper, 2025 · strength 0.25
   • Paper Enhancing PDAC therapy: Decitabine-olaparib synergy targets KRAS-dependent tumors. DOI 10.1016/j.isci.2025.111842↗
3. Alfredo Budillon · 1 shared paper, 2024 · strength 0.20
   • Paper The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promi… DOI 10.1186/s13046-024-03117-5↗
4. Maria Serena Roca · 1 shared paper, 2024 · strength 0.20
   • Paper The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promi… DOI 10.1186/s13046-024-03117-5↗
5. Damiano D. Caputo · 1 shared paper, 2024 · strength 0.20
   • Paper The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promi… DOI 10.1186/s13046-024-03117-5↗
6. Giovanni Blandino · 1 shared paper, 2024 · strength 0.20
   • Paper The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promi… DOI 10.1186/s13046-024-03117-5↗
7. Giulio Caracciolo · 1 shared paper, 2024 · strength 0.20
   • Paper The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promi… DOI 10.1186/s13046-024-03117-5↗
8. Giulia Piaggio · 1 shared paper, 2024 · strength 0.20
   • Paper The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promi… DOI 10.1186/s13046-024-03117-5↗
9. Christian P. Pilarsky · 1 shared paper, 2024 · strength 0.20
   • Paper The cross-talk between the macro and micro-environment in precursor lesions of pancreatic cancer leads to new and promi… DOI 10.1186/s13046-024-03117-5↗
10. Alessandro Carugo · 1 shared paper, 2019 · strength 0.07
    • Paper Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocar… DOI 10.1158/0008-5472.can-19-0187↗
11. Ya’an Kang · 1 shared paper, 2019 · strength 0.07
    • Paper Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocar… DOI 10.1158/0008-5472.can-19-0187↗
12. Hideo Tomihara · 1 shared paper, 2019 · strength 0.07
    • Paper Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocar… DOI 10.1158/0008-5472.can-19-0187↗
13. Jason B. Fleming · 1 shared paper, 2019 · strength 0.07
    • Paper Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocar… DOI 10.1158/0008-5472.can-19-0187↗
14. Michael P. Kim · 1 shared paper, 2019 · strength 0.07
    • Paper Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocar… DOI 10.1158/0008-5472.can-19-0187↗
15. Davide Melisi · 1 shared paper, 2019 · strength 0.07
    • Paper Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocar… DOI 10.1158/0008-5472.can-19-0187↗
16. Giulio Francesco Draetta · 1 shared paper, 2019 · strength 0.07
    • Paper Predictive Signatures Inform the Effective Repurposing of Decitabine to Treat KRAS-Dependent Pancreatic Ductal Adenocar… DOI 10.1158/0008-5472.can-19-0187↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.